Highly Multiplexed Cytokine Analysis in Small Animal Models

Explore three case studies showing how researchers utilized IsoPlexis’ Functional Proteomics to accelerate vaccine development, create a model for T Cell persistence in solid tumors, and screen CAR-T products.

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this we discuss:

Functional proteomics accelerates vaccine development
A model for T Cell persistence in solid tumors
Highly multiplexed single-cell functional proteomics on a small scale
Screening CAR-T products with functional proteomics
A Deeper Look

More about this

Screening CAR-T Products with Functional Proteomics

Hepatocellular carcinoma is the most common type of liver cancer and is a leading cause of cancer-related deaths worldwide.

Despite advances in prevention techniques, screening, and new technologies in diagnosis and treatment, the incidence and mortality rates continue to rise.

Download this eBook to learn how researchers D. Li et al., leveraged IsoPlexis’ technology to study GPC3-targeted CAR-T cells and why they believe these cells represent a promising strategy for the treatment of patients with hepatocellular carcinoma.

awards-bar-3-wide-color-right
awards-bar-4-wide-color-left
Get the